Pfizer’s Accupril Patent Case Against Teva Heads Back To Court
This article was originally published in The Pink Sheet Daily
Executive Summary
A Newark, N.J. federal judge must reconsider whether an Accupril patent is valid and is infringed by Teva’s quinapril generic, an appeals court says.